Get the Stockscreener App
1.24
2.71%
-0.02
Brainstorm Cell Therapeutics Inc Stock (BCLI) Forecast
The Brainstorm Cell Therapeutics Inc (BCLI) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.6447, representing a -48.01% decrease from the current price of $1.24. The highest analyst price target is $0.8757, and the lowest is $0.4138.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BCLI Price Target
Average 7.4216
(+498.51% Upside)
Is Brainstorm Cell Therapeutics Inc (BCLI) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 26.98 | Buy |
| STOCH(9,6) | 32.18 | Neutral |
| STOCHRSI(14) | 79.13 | Neutral |
| MACD(12,26) | -0.3269 | Buy |
| ADX(14) | 34.00 | Sell |
| William %R | -77.78 | Neutral |
| CCI(14) | -35.48 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.209
Buy
|
1.2971
Sell
|
| MA20 |
1.51
Sell
|
1.51
Sell
|
| MA50 |
2.3031
Sell
|
2.2852
Sell
|
| MA100 |
3.6215
Sell
|
3.3844
Sell
|
| MA200 |
5.2596
Sell
|
5.2036
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, BCLI could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 10 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on BCLI, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 26.98 indicates that BCLI is oversold. This indicates that BCLI price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 32.18 indicates that BCLI is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 79.13 indicates that BCLI is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 34 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -35.48 indicates that BCLI is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term BCLI price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Brainstorm Cell Therapeutics Inc financial reports and earnings history, Brainstorm Cell Therapeutics Inc (BCLI) stock could reach $3.2546 by 2030, $0.2334 by 2040 and $5.8041 by 2050. See the projected annual prices until 2050 of the Brainstorm Cell Therapeutics Inc stock below:
- Brainstorm Cell Therapeutics Inc (BCLI) is expected to reach an average price of $1.121 in 2035, with a high prediction of $1.2945 and a low estimate of $1.1954. This indicates an $-9.60% rise from the last recorded price of $1.24.
- Brainstorm Cell Therapeutics Inc (BCLI) stock is projected to chart a bullish course in 2040, with an average price target of $0.2496, representing an $-79.87% surge from its current level. The forecast ranges from a conservative $0.4896 to a sky-high $0.2334.
- Our analysts predict Brainstorm Cell Therapeutics Inc (BCLI) to jump 47.65% by 2045, soaring from $1.7434 to an average price of $1.8308, potentially reaching $1.406. While $1.7434 is the low estimate, the potential upside is significant.
- Brainstorm Cell Therapeutics Inc (BCLI) stock is expected to climb by 2050, reaching an average of $5.3645, a $332.62% jump from its current level. However, a wide range of estimates exists, with high and low targets of $5.8041 and $5.7345, respectively, highlighting the market's uncertainty.
Brainstorm Cell Therapeutics Inc Stock (BCLI) Year by Year Forecast
Brainstorm Cell Therapeutics Inc Stock (BCLI) Price Forecast for 2024
Our forecast for BCLI stock price in 2024 now indicates an average price target of $0.5522 with a high forecast of $1.0409 and a low forecast of $0.0635. The average prediction reflects an decrease of -55.47% from the last recorded price of $1.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $0.7857 | $0.4138 | $0.8757 | -36.64% |
Brainstorm Cell Therapeutics Inc Stock (BCLI) Price Forecast for 2025
Brainstorm Cell Therapeutics Inc Stock (BCLI) is expected to reach an average price of $7.9274 in 2025, with a high prediction of $15.32 and a low estimate of $0.537. This indicates an +539.31% rise from the last recorded price of $1.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $1.0689 | $0.537 | $1.3589 | -13.80% |
| February, 2025 | $1.0115 | $0.9015 | $1.3602 | -18.43% |
| March, 2025 | $3.864 | $0.9121 | $6.974 | +211.62% |
| April, 2025 | $1.4973 | $1.186 | $5.7247 | +20.75% |
| May, 2025 | $3.2918 | $1.3579 | $3.4498 | +165.47% |
| June, 2025 | $2.3924 | $2.1624 | $4.5117 | +92.93% |
| July, 2025 | $7.4156 | $2.183 | $7.7156 | +498.03% |
| August, 2025 | $10.46 | $6.3962 | $10.78 | +743.40% |
| September, 2025 | $10.04 | $9.2507 | $14.43 | +709.74% |
| October, 2025 | $9.8839 | $8.6402 | $11.88 | +697.09% |
| November, 2025 | $14.27 | $9.4496 | $14.43 | +1,051% |
| December, 2025 | $7.4297 | $6.0991 | $15.32 | +499.17% |
Brainstorm Cell Therapeutics Inc Stock (BCLI) Price Forecast for 2026
The predicted value for Brainstorm Cell Therapeutics Inc (BCLI) in 2026 is set at an average of $5.435. Estimates vary from a peak of $10.23 to a trough of $0.639, indicating an +338.31% surge from the present price of $1.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.6923 | $1.2317 | $10.23 | +117.12% |
| February, 2026 | $2.7849 | $1.9742 | $3.3542 | +124.59% |
| March, 2026 | $2.6274 | $1.8761 | $2.9155 | +111.89% |
| April, 2026 | $4.4806 | $2.6281 | $5.6994 | +261.34% |
| May, 2026 | $1.7932 | $0.7019 | $2.6313 | +44.61% |
| June, 2026 | $1.3158 | $1.1045 | $2.3839 | +6.11% |
| July, 2026 | $1.099 | $0.639 | $1.5577 | -11.37% |
| August, 2026 | $1.7116 | $0.9796 | $1.9015 | +38.03% |
| September, 2026 | $1.2948 | $1.1248 | $1.9035 | +4.42% |
| October, 2026 | $1.8173 | $1.0361 | $2.067 | +46.56% |
| November, 2026 | $1.3699 | $1.1186 | $1.848 | +10.48% |
| December, 2026 | $1.2231 | $1.0418 | $1.7318 | -1.36% |
Brainstorm Cell Therapeutics Inc Stock (BCLI) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Brainstorm Cell Therapeutics Inc (BCLI) is $1.6858, with a high forecast of $2.5728 and a low forecast of $0.7989. This indicates an +35.95% increase from the last price of $1.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.0557 | $1.0084 | $1.2744 | -14.86% |
| February, 2027 | $0.9483 | $0.8163 | $1.3383 | -23.53% |
| March, 2027 | $1.5215 | $0.7989 | $2.2715 | +22.70% |
| April, 2027 | $1.684 | $1.4121 | $2.5728 | +35.81% |
| May, 2027 | $1.2866 | $0.9053 | $1.6747 | +3.76% |
| June, 2027 | $1.1898 | $1.0585 | $1.4972 | -4.05% |
| July, 2027 | $1.6324 | $1.1205 | $1.7524 | +31.64% |
| August, 2027 | $1.405 | $1.355 | $1.9337 | +13.30% |
| September, 2027 | $1.3482 | $0.9969 | $1.6662 | +8.72% |
| October, 2027 | $1.3007 | $1.1107 | $1.4501 | +4.90% |
| November, 2027 | $1.2633 | $1.082 | $1.4014 | +1.88% |
| December, 2027 | $2.0065 | $1.0052 | $2.0465 | +61.82% |
Brainstorm Cell Therapeutics Inc Stock (BCLI) Price Forecast for 2028
In 2028, Brainstorm Cell Therapeutics Inc (BCLI) is projected to reach an average price of $1.6483, with a high projection of $3.2172 and a low estimate of $0.0794. This indicates an +32.92% rise from the last price of $1.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.8991 | $1.6672 | $3.2172 | +53.15% |
| February, 2028 | $3.0116 | $1.6597 | $3.1516 | +142.87% |
| March, 2028 | $2.2049 | $1.6536 | $3.0823 | +77.81% |
| April, 2028 | $0.3874 | $0.1274 | $2.3023 | -68.76% |
| May, 2028 | $0.4406 | $0.0794 | $0.8306 | -64.46% |
| June, 2028 | $0.3032 | $0.1305 | $0.5325 | -75.55% |
| July, 2028 | $1.7458 | $0.1941 | $1.7758 | +40.79% |
| August, 2028 | $0.499 | $0.299 | $1.8364 | -59.76% |
| September, 2028 | $1.7316 | $0.3496 | $2.3709 | +39.64% |
| October, 2028 | $1.9541 | $1.4448 | $2.3265 | +57.59% |
| November, 2028 | $2.0573 | $1.5067 | $2.186 | +65.91% |
| December, 2028 | $1.1199 | $1.0393 | $2.368 | -9.69% |
Brainstorm Cell Therapeutics Inc Stock (BCLI) Price Forecast for 2029
The 2029 price forecast for Brainstorm Cell Therapeutics Inc Stock (BCLI) is $1.4811 on average, with a high prediction of $2.951 and a low estimate of $0.0111. This represents an +19.44% increase from the previous price of $1.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.9531 | $0.5825 | $1.2035 | -23.14% |
| February, 2029 | $0.8157 | $0.545 | $1.0238 | -34.22% |
| March, 2029 | $0.1625 | $0.1489 | $0.9763 | -86.90% |
| April, 2029 | $0.5892 | $0.0111 | $0.5822 | -52.49% |
| May, 2029 | $0.5356 | $0.5556 | $0.5673 | -56.81% |
| June, 2029 | $0.4034 | $0.424 | $0.4853 | -67.47% |
| July, 2029 | $0.3478 | $0.4183 | $0.4021 | -71.95% |
| August, 2029 | $0.2143 | $0.2575 | $0.3102 | -82.72% |
| September, 2029 | $0.1761 | $0.2229 | $0.147 | -85.80% |
| October, 2029 | $0.0982 | $0.1467 | $0.1379 | -92.08% |
| November, 2029 | $0.1027 | $0.0207 | $0.3315 | -91.72% |
| December, 2029 | $3.081 | $0.0168 | $2.951 | +148.47% |
Brainstorm Cell Therapeutics Inc Stock (BCLI) Price Forecast for 2030
Brainstorm Cell Therapeutics Inc Stock (BCLI) is expected to reach an average price of $2.0281 in 2030, with a high forecast of $3.9481 and a low forecast of $0.1081. This signifies an +63.55% surge from the last price of $1.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.2846 | $3.2397 | $3.2546 | +164.89% |
| February, 2030 | $2.3794 | $2.7094 | $3.0133 | +91.89% |
| March, 2030 | $3.0543 | $2.8382 | $2.7543 | +146.31% |
| April, 2030 | $2.9392 | $3.0392 | $2.9405 | +137.03% |
| May, 2030 | $2.7127 | $2.6866 | $2.5876 | +118.77% |
| June, 2030 | $2.8026 | $2.6689 | $2.6015 | +126.02% |
| July, 2030 | $2.4532 | $2.7212 | $2.685 | +97.84% |
| August, 2030 | $2.586 | $2.4099 | $2.406 | +108.55% |
| September, 2030 | $1.8509 | $1.9509 | $2.1405 | +49.27% |
| October, 2030 | $0.9135 | $1.8645 | $1.9308 | -26.33% |
| November, 2030 | $0.3894 | $0.1081 | $3.9481 | -68.60% |
| December, 2030 | $1.3242 | $1.5368 | $1.1042 | +6.79% |
1.80%
0.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):